{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:46:25Z","timestamp":1790952385830,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.kint.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T06:21:29Z","timestamp":1535610089000},"page":"887-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["HIF-1\u03b1 promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"94","author":[{"given":"Andre","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Klanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Willam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Schley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kunzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.06.008_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.06.008_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2018.06.008_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.kint.2018.06.008_bib5","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.06.008_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","article-title":"Involvement of hypoxia-inducible transcription factors in polycystic kidney disease","volume":"170","author":"Bernhardt","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2018.06.008_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1681\/ASN.2013030209","article-title":"Hypoxia-inducible factor-1alpha causes renal cyst expansion through calcium-activated chloride secretion","volume":"25","author":"Buchholz","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib8","doi-asserted-by":"crossref","first-page":"R1207","DOI":"10.1152\/ajpregu.00202.2014","article-title":"Determinants of renal tissue hypoxia in a rat model of polycystic kidney disease","volume":"307","author":"Ow","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.kint.2018.06.008_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","article-title":"Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study","volume":"70","author":"Wei","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.06.008_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/micc.12022","article-title":"Polycystic kidneys have decreased vascular density: a micro-CT study","volume":"20","author":"Xu","year":"2013","journal-title":"Microcirculation"},{"key":"10.1016\/j.kint.2018.06.008_bib11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","article-title":"Expression of hypoxia-inducible factor-1 alpha and -2 alpha in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/cdd.2008.12","article-title":"Biology of HIF-1alpha","volume":"15","author":"Weidemann","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.kint.2018.06.008_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.06.008_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00109-010-0715-1","article-title":"Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion","volume":"89","author":"Buchholz","year":"2011","journal-title":"J\u00a0Mol Med Berl"},{"key":"10.1016\/j.kint.2018.06.008_bib15","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.0337.2000","article-title":"Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys","volume":"282","author":"Schwiebert","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.06.008_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11302-016-9532-5","article-title":"P2Y2R is a direct target of HIF-1alpha and mediates secretion-dependent cyst growth of renal cyst-forming epithelial cells","volume":"12","author":"Kraus","year":"2016","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.kint.2018.06.008_bib17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ki.2013.418","article-title":"Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells","volume":"85","author":"Buchholz","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.06.008_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/dvg.20207","article-title":"Transgenic mice expressing tamoxifen-inducible Cre for somatic\u00a0gene modification in renal epithelial cells","volume":"44","author":"Lantinga-van Leeuwen","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.kint.2018.06.008_bib19","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","article-title":"Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice","volume":"16","author":"Lantinga-van Leeuwen","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2018.06.008_bib20","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1681\/ASN.2016040425","article-title":"Variable cyst development in autosomal dominant polycystic kidney disease: the biologic context","volume":"27","author":"Leonhard","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","article-title":"Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease","volume":"222","author":"Hassane","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.kint.2018.06.008_bib22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.06.008_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneph.2015.193","article-title":"HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond","volume":"12","author":"Maxwell","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib25","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.ajpath.2012.07.010","article-title":"Selective stabilization of HIF-1alpha in renal tubular cells by 2-oxoglutarate analogues","volume":"181","author":"Schley","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2018.06.008_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.kint.2018.06.008_bib27","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD","volume":"21","author":"Bernhardt","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD","volume":"69","author":"Gupta","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.06.008_bib29","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0608382104","article-title":"Acute postnatal ablation of Hif-2alpha results in anemia","volume":"104","author":"Gruber","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.06.008_bib30","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI83551","article-title":"Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin","volume":"126","author":"Kobayashi","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2018.06.008_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00109-015-1337-4","article-title":"Glucose promotes secretion-dependent renal cyst growth","volume":"94","author":"Kraus","year":"2016","journal-title":"J\u00a0Mol Med Berl"},{"key":"10.1016\/j.kint.2018.06.008_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.06.008_bib33","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","article-title":"Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor","volume":"66","author":"Rankin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.kint.2018.06.008_bib34","doi-asserted-by":"crossref","first-page":"F740","DOI":"10.1152\/ajprenal.00167.2016","article-title":"Acute kidney injury induces hallmarks of polycystic kidney disease","volume":"311","author":"Kurbegovic","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.06.008_bib35","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","article-title":"Renal injury is a third hit promoting rapid development of adult polycystic kidney disease","volume":"18","author":"Takakura","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2018.06.008_bib36","doi-asserted-by":"crossref","first-page":"F721","DOI":"10.1152\/ajprenal.00546.2010","article-title":"Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury","volume":"300","author":"Basile","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.06.008_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.kint.2018.06.008_bib38","doi-asserted-by":"crossref","first-page":"21276","DOI":"10.1073\/pnas.0903978106","article-title":"Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model","volume":"106","author":"Bernhardt","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.06.008_bib39","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1681\/ASN.2010121249","article-title":"Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury","volume":"22","author":"Schley","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1681\/ASN.2007040419","article-title":"HIF activation protects from acute kidney injury","volume":"19","author":"Weidemann","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.06.008_bib41","doi-asserted-by":"crossref","first-page":"F1235","DOI":"10.1152\/ajprenal.00348.2010","article-title":"Hypoxia-inducible factor-1alpha (HIF-1alpha) and autophagy in polycystic kidney disease (PKD)","volume":"300","author":"Belibi","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.06.008_bib42","doi-asserted-by":"crossref","first-page":"F636","DOI":"10.1152\/ajprenal.00265.2011","article-title":"2-Hydroxyestradiol slows progression of experimental polycystic kidney disease","volume":"302","author":"Anderson","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.06.008_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejmech.2012.01.033","article-title":"Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors","volume":"49","author":"Xia","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.kint.2018.06.008_bib44","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1 alpha is required for solid tumor\u00a0formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.kint.2018.06.008_bib45","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ki.2015.214","article-title":"Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to\u00a0enhance tubulogenesis","volume":"88","author":"Schley","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.06.008_bib46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ki.2013.535","article-title":"The calcium-activated chloride channel Anoctamin 1 contributes to the regulation of renal function","volume":"85","author":"Faria","year":"2014","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818304447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818304447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:50:48Z","timestamp":1758761448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818304447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0085253818304447"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.06.008","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-1\u03b1 promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}